The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The contribution of de novo coding mutations to autism spectrum disorder
Open accessAbstract
Whole exome sequencing has proven to be a powerful tool for understanding the genetic architecture of human disease. Here we apply it to more than 2,500 simplex families, each having a child with an autistic spectrum disorder. By comparing affected to unaffected siblings, we show that 13% of de novo missense mutations and 43% of de novo likely gene-disrupting (LGD) mutations contribute to 12% and 9% of diagnoses, respectively. Including copy number variants, coding de novo mutations contribute to about 30% of all simplex and 45% of female diagnoses. Almost all LGD mutations occur opposite wild-type alleles. LGD targets in affected females significantly overlap the targets in males of lower intelligence quotient (IQ), but neither overlaps significantly with targets in males of higher IQ. We estimate that LGD mutation in about 400 genes can contribute to the joint class of affected females and males of lower IQ, with an overlapping and similar number of genes vulnerable to contributory missense mutation. LGD targets in the joint class overlap with published targets for intellectual disability and schizophrenia, and are enriched for chromatin modifiers, FMRP-associated genes and embryonically expressed genes. Most of the significance for the latter comes from affected females.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“including that, prima facie , most proteins encoded by ASD risk genes are involved either in synaptic structure and function or chromatin modification and regulation of gene expression 38,46,47,58 (Fig. 3).”
From Autism spectrum disorder (2020) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rare inherited and de novo variants are major contributors to individual risk for autism spectrum disorder (ASD)”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Iossifov et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By contrast, de novo mutations, mostly copy number variants (CNVs) and gene disrupting point mutations, have larger individual effects, but collectively explain <5% of the overall liability 1-3 and far less of the heritability.”
From Identification of common genetic risk variants for autism spectrum disorder (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ASD affects 1-1.5% of individuals and is highly heritable, with both common and rare variants contributing to its etiology 1-4 .”
From Identification of common genetic risk variants for autism spectrum disorder (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, for the majority of large CNVs, studies have not found evidence for the existence of a single driver gene (De Rubeis et al., 2014; Iossifov et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For instance, several microdeletions lead to loss of various lengths of the C-terminal portion of Dock4 protein 19, 21, 26, which is responsible for its Rac1-activating ability 27.”
From Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function. (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recent studies have identified a number of DOCK4 variations associated with ASD, including both single nucleotide variations (SNVs) and chromosome microdeletions or duplications (Supplementary Table 1) 18–26.”
From Autism-like social deficit generated by Dock4 deficiency is rescued by restoration of Rac1 activity and NMDA receptor function. (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Next-generation sequencing identified one intronic114, two missense133,134, and two nonsense variants in autism patients104,114, and the functional consequences of these variants remain to be established (Table 2u).”
From The WAVE complex in developmental and adulthood brain disorders (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredIn the citing paper
“The major risk factors for autism spectrum disorder (ASD) are genetic and include a variety of rare and common alleles, including rare de novo copy number variants (CNVs)1 or protein-truncating SNPs and indels of large effect2 and common polygenic risk that is measured as the sum of thousands of common alleles with small effects3.”
From A phenotypic spectrum of autism is attributable to the combined effects of rare variants, polygenic risk and sex (2022) · cites this paper as [2]
In the citing paper
“The possibility of a “female protective effect” (FPE) against ASD has been described extensively and has received consistent support from the results of genetic studies of de novo variants.4, 5, 6, 7, 8, 9, 10, 11, 12, 13”
From The female protective effect against autism spectrum disorder (2022) · cites this paper as [11]
In the citing paper
“Many types of ASD-associated de novo variants are observed more frequently in female cases.4, 5, 6, 7, 8, 9, 10, 11, 12, 13”
From The female protective effect against autism spectrum disorder (2022) · cites this paper as [11]
In the citing paper
“We also demonstrated that the genetic architecture in this self-reported cohort is similar to published, clinically confirmed ASD cohorts.3,4,7”
From Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes (2019) · cites this paper as [3]
In the citing paper
“Over the past decade, genomic studies focused on de novo, likely gene disrupting (dnLGD) variants (stopgain, frameshift, and essential splice site) have identified ~100 high-confidence ASD risk genes or loci.3,4”
From Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes (2019) · cites this paper as [3]
In the citing paper
“individuals with ASD have a two- to three-fold increase in the number of rare copy number variations (CNVs) and de novo loss-of-function (nonsense, frameshift, and splice site) variants compared to their unaffected siblings11–14.”
From Genome-wide detection of tandem DNA repeats that are expanded in autism (2020) · cites this paper as [12]
In the citing paper
“the application of two SNV callers identified 77 additional de novo SNVs previously missed 9.”
From Excess of rare, inherited truncating mutations in autism (2015) · cites this paper as [9]
In the citing paper
“In addition, we also validated by Sanger sequencing another 132 previously called 9 but not confirmed events, resulting in a total of 209 validated de novo SNVs and indels (Supplementary Table 2).”
From Excess of rare, inherited truncating mutations in autism (2015) · cites this paper as [9]
In the citing paper
“Most of these mutations also decrease IQ and ID is an important comorbidity of ASD (Buja et al., 2018; Iossifov et al., 2014), which is consistent with previous work identifying dozens of known severe, rare medical genetic syndromes associated with ASD (reviewed in (Abrahams and Geschwind, 2008; Geschwind, 2009)).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“Although each gene accounts for only a small fraction of cases, rare de novo variation is predicted to account for ~15% of ASD cases (Iossifov et al., 2014).”
From Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“The application of this approach to exomes or whole genomes in large family samples has since become the most effective strategy for identifying ASD susceptibility genes (De Rubeis et al., 2014; Iossifov et al., 2014; Sanders et al., 2015; Satterstrom et al., 2018).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“As would be expected for variants with large effects, subjects that carry de novo mutations have lower non-verbal IQs than subjects who do not (Iossifov et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“It is estimated that de novo mutations of genes contribute in approximately 30% of cases, including 25% of boys and 45% of girls (Iossifov et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Iossifov et al., 2014
In the citing paper
“Moreover, 20 of these lncRNAs have been shown to interact with microRNA (miRNA)–protein complexes, and 9 with the fragile X mental retardation protein (FMRP), whose mRNA targets are enriched in ASD risk genes9,10.”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [9]
In the citing paper
“In this regard, it is notable that the observed transcriptome changes are consistent with an ongoing process that is triggered largely by genetic and prenatal factors3,9,10,23, but that evolves during the first decade of brain development.”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [9]
In the citing paper
“We previously computed that genes with de novo (DN) likely gene-disruptive (LGD) mutations in children with autism spectrum disorders (ASD) have high vulnerability: disruptive mutations in many of these genes, the vulnerable autism genes, will have a high likelihood of resulting in ASD.”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“Moreover, the target genes in affected and unaffected individuals have length distributions that are closely matched (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“There are 39 such targets (10,18), and we previously estimated that ∼90% of these targets are true causal targets.”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“All gene classes enriched for autism targets show a decreased load of UR LGD variants, especially the FMRP-associated class, as previously noted (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“We also find a strong signal for biased transmission in the functional categories of genes previously associated with ASD (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“We computed that roughly half of the time in males, a DN LGD mutation within an autism gene will produce severe ASD (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“From recurrence and overlap analysis of DN LGD targets, we estimate ∼500 causative ASD target genes in the affected individuals with lower intelligence quotients (IQ), and these targets are enriched in certain functional classes (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“The increase in the rate of DN LGD mutation in affected children compared with the rate in their unaffected siblings was used to estimate the proportion (0.42) of 391 observed DN variants in the affected children that contribute to affected status (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“Although our previous work had shown that embryonic genes were enriched as DN targets (10), their involvement in transmission is greater than we would have predicted.”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“First, a substantial signal from transmission is seen in the set of “embryonic” genes (10).”
From Low load for disruptive mutations in autism genes and their biased transmission (2015) · cites this paper as [10]
In the citing paper
“Thus, many severe mutations do not converge on one specific phenotype but instead seem to cause a range of clinical disorders74,76,80,81,84,87,91.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [76]
In the citing paper
“suggesting that females are affected by more severe genetic hits in ASD, an observation that has been replicated in exome-sequencing studies76,117.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [76]
In the citing paper
“This elevation of protein-compromising URVs was several times larger than an analogously elevated rate for de novo mutations”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [13]
In the citing paper
“These data yielded an elevation of about 0.03 such DNMs per exome, based on the difference between rates of 0.185 (95% CI 0.151-0.219) for individuals with schizophrenia12 and 0.156 (95% CI 0.139-0.174) for unaffected individuals13.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [13]
In the citing paper
“Subsets of human genes have been previously identified as “missense constrained” (based on a lack of functional coding variation in controls) or “loss-of-function intolerant” (based on a smaller-than-expected number of loss-of-function mutations in population-scale data)13,21.”
From Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia (2016) · cites this paper as [13]
In the citing paper
“ANK2 has been consistently associated with ASD (22,26,80) and also with cardiac arrhythmia (OMIM no.600919) (78).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“In the case of paternal age, one mediating mechanism lies in the increased rate of de novo SNV and CNV with advancing paternal age (22,24,25,43,44).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“To date, in addition to causal and highly penetrant genes and genomic loci identified before whole-exome sequencing (15,30), over 50 high-risk genes have emerged from the large-scale sequencing studies (21)(22)(23)(24)(25)(26), most under a model of autosomal dominant variation.”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“The model helps in the understanding of the relatively high risk for siblings of individuals diagnosed with ASD (13,46), the increased mutational burden in ASD probands compared with their unaffected siblings (22,28), etiological heterogeneity even within pairs of affected siblings (47,48) and, as we shall discuss further, the variable expressivity of certain loci (49,50) (Fig. 1).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“Rare genetic risk variation identified to date, in contrast, has a very substantial effect on individual risk.Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations that were previously identifiable only by traditional genetic approaches and targeted sequencing (14,15).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“CHD2 has been associated with ASD (22,23), ID (73), epilepsy (82,87) and photosensitivity (83).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“TBR1 has been implicated in ASD (21,22,25,26) and ID (73).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“Mutations in CHD2 have been detected in individuals with a diagnosis of ASD (22), ID (73) or epilepsy (82,83,87,89)”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [22]
In the citing paper
“such rare high-confidence mutations tend to be significantly enriched in genes involved in synaptic functions, transcriptional regulation, and chromatin remodeling functions, and/or are downstream targets of the fragile X syndrome protein (FMRP) complex.1, 3”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [3]
In the citing paper
“When considering known ASD-associated missense variants,3 we also found substantial enrichment (33%, 48/145, OR=2.21, P=0.0021) (Figure 1b).”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [3]
In the citing paper
“Albeit rare, de novo mutations have emerged as substantial contributors to ASD risk [83, 165, 166, 254, 261, 309].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [165]
In the citing paper
“Chromodomain helicase DNA-binding protein 8 (CHD8), encoding a chromatin modifying gene on chromosome 14q11.2, is one of the high-penetrance ASD risk genes recently identified by sequencing studies [83, 165, 261, 347].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [165]
In the citing paper
“Using the WW data, we observe enrichment at an empirical P ≤ .05 for the synaptic co-expression network M13 [48], Mendelian disease genes [11], and both human (HARs) and primate-accelerated regions (PARs) [49]. None of these enrichments exceeded the experiment-wise corrected P ≤ .05.”
In the citing paper
“For example, FMRP biology has also been implicated in all three diagnoses [11].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationDNA methylation and epigenetic inheritance
Holliday, R. (1990) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1990.0015 · Cited by 2,290
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
Self-citationRate of de novo mutations and the importance of father’s age to disease risk
Kong, A., Frigge, M. L., Masson, G., Besenbacher, S., Sulem, P., Magnusson, G., Gudjonsson, S. A., Sigurdsson, A., Jonasdottir, A., Jonasdottir, A., et al. (2012) · Nature · doi:10.1038/nature11396 · Cited by 2,134
Spatio-temporal transcriptome of the human brain
Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A. M. M., Pletikos, M., Meyer, K. A., Sedmak, G., et al. (2011) · Nature · doi:10.1038/nature10523 · Cited by 2,084
Self-citationDe novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Self-citation
Cited by
Sorted by citations
Items 101–200 of 1,014
The Role of Epigenetic Change in Autism Spectrum Disorders
Loke, Y. J., Hannan, A. J., & Craig, J. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00107 · Cited by 266
Genomic Medicine–Progress, Pitfalls, and Promise
Shendure, J., Findlay, G. M., & Snyder, M. W. (2019) · Cell · doi:10.1016/j.cell.2019.02.003 · Cited by 263
Self-citationMcConnell, M. J., Moran, J. V., Abyzov, A., Akbarian, S., Bae, T., Cortes-Ciriano, I., Erwin, J. A., Fasching, L., Flasch, D. A., Freed, D., et al. (2017) · Science · doi:10.1126/science.aal1641 · Cited by 262
Genetic Control of Expression and Splicing in Developing Human Brain Informs Disease Mechanisms
Walker, R. L., Ramaswami, G., Hartl, C., Mancuso, N., Gandal, M. J., de la Torre-Ubieta, L., Paşaniuc, B., Stein, J. L., & Geschwind, D. H. (2019) · Cell · doi:10.1016/j.cell.2019.09.021 · Cited by 262
Artificial intelligence for precision medicine in neurodevelopmental disorders
Uddin, M. J., Wang, Y., & Woodbury‐Smith, M. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0191-0 · Cited by 261
Getting to the cores of autism
Iakoucheva, L. M., Muotri, A. R., & Sebat, J. (2019) · Cell · doi:10.1016/j.cell.2019.07.037 · Cited by 260
“Aswould beexpected for variantswith large effects, subjects that carry de novo mutations have lower nonverbal IQs than subjects who do not (Iossifov et al., 2014).”
BackgroundMethodInfluentialWang, P., Mokhtari, R., Pedrosa, E., Kirschenbaum, M. A., Bayrak, C., Zheng, D., & Lachman, H. M. (2017) · Molecular Autism · doi:10.1186/s13229-017-0124-1 · Cited by 260
Kosmicki, J. A., Sochat, V., Duda, M., & Wall, D. P. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.7 · Cited by 259
Neurobiological bases of autism–epilepsy comorbidity: a focus on excitation/inhibition imbalance
Bozzi, Y., Provenzano, G., & Casarosa, S. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13595 · Cited by 250
Genetics and epigenetics of autism spectrum disorder—current evidence in the field
Wiśniowiecka‐Kowalnik, B., & Nowakowska, B. (2019) · Journal of Applied Genetics · doi:10.1007/s13353-018-00480-w · Cited by 249
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
Feliciano, P., Zhou, X., Astrovskaya, I., Turner, T. N., Wang, T., Brueggeman, L., Barnard, R., Hsieh, A., Snyder, L. G., Muzny, D. M., et al. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0093-8 · Cited by 247
Self-citationDevelopmental mechanism of the periodic membrane skeleton in axons
Zhong, G., He, J., Zhou, R., Lorenzo, D. N., Babcock, H. P., Bennett, V., & Zhuang, X. (2014) · eLife · doi:10.7554/elife.04581 · Cited by 246
Somatic mosaicism and neurodevelopmental disease
D’Gama, A. M., & Walsh, C. A. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0257-3 · Cited by 249
A map of constrained coding regions in the human genome
Havrilla, J. M., Pedersen, B. S., Layer, R. M., & Quinlan, A. R. (2018) · Nature Genetics · doi:10.1038/s41588-018-0294-6 · Cited by 242
Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits
Platt, R. J., Zhou, Y., Slaymaker, I. M., Shetty, A. S., Weisbach, N. R., Kim, J.-A., Sharma, J., Desai, M., Sood, S., Kempton, H. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.052 · Cited by 240
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders
Heyes, S., Pratt, W. S., Rees, E., Dahimène, S., Ferron, L., Owen, M. J., & DOLPHIN, A. C. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.002 · Cited by 241
Genome-wide detection of tandem DNA repeats that are expanded in autism
Trost, B., Engchuan, W., Nguyen, C. M., Thiruvahindrapuram, B., Dolzhenko, E., Backstrom, I., Mirceta, M., Mojarad, B. A., Yin, Y., Dov, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2579-z · Cited by 238
Genomics, convergent neuroscience and progress in understanding autism spectrum disorder
Willsey, H. R., Willsey, A. J., Wang, B., & State, M. W. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00576-7 · Cited by 239
Self-citationSingh, T., Walters, J. T. R., Johnstone, M., Curtis, D., Suvisaari, J., Torniainen, M., Rees, E., Iyegbe, C., Blackwood, D., McIntosh, A. M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3903 · Cited by 231
Genetics of autism spectrum disorder
Ramaswami, G., & Geschwind, D. H. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00021-x · Cited by 233
Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families
Leppä, V., Kravitz, S. N., Martin, C. L., Andrieux, J., Caignec, C. L., Martin‐Coignard, D., DyBuncio, C. T., Sanders, S., Lowe, J. K., Cantor, R. M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.06.036 · Cited by 229
Self-citationA transcription factor atlas of directed differentiation
Joung, J., Ma, S., Tay, T., Geiger-Schuller, K., Kirchgatterer, P. C., Verdine, V. K., Guo, B., Arias-García, M. A., Allen, W. E., Singh, A., et al. (2023) · Cell · doi:10.1016/j.cell.2022.11.026 · Cited by 229
Genetics of intellectual disability in consanguineous families
Hu, H., Kahrizi, K., Musante, L., Fattahi, Z., Herwig, R., Hosseini, M., Oppitz, C., Abedini, S. S., Suckow, V., Larti, F., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-017-0012-2 · Cited by 225
The road to precision psychiatry: translating genetics into disease mechanisms
Gandal, M. J., Leppa, V., Won, H., Parikshak, N. N., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4409 · Cited by 223
denovo-db: a compendium of humande novovariants
Turner, T. N., Qian, Y., Krumm, N., Huddleston, J., Hoekzema, K., Stessman, H. A. F., Doebley, A.-L., Bernier, R., Nickerson, D. A., & Eichler, E. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw865 · Cited by 221
Self-citationMolecular mechanisms of astrocyte-induced synaptogenesis
Baldwin, K. T., & Eroğlu, Ç. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.05.006 · Cited by 219
Performance evaluation of pathogenicity-computation methods for missense variants
Li, J., Zhao, T., Zhang, Y., Zhang, K., Shi, L., Chen, Y., Wang, X., & Sun, Z. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky678 · Cited by 219
Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk
Castel, S. E., Cervera, A., Mohammadi, P., Aguet, F., Reverter, F., Wolman, A., Guigo, R., Iossifov, I., Vasileva, A., & Lappalainen, T. (2018) · Nature Genetics · doi:10.1038/s41588-018-0192-y · Cited by 217
Self-citationWidespread RNA editing dysregulation in brains from autistic individuals
Tran, S. S., Jun, H.-I., Bahn, J. H., Azghadi, A., Ramaswami, G., Nostrand, E. L. V., Nguyen, T. B., Hsiao, Y.-H. E., Lee, C., Pratt, G. A., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0287-x · Cited by 221
Genome-wide characteristics of de novo mutations in autism
Yuen, R. K., Merico, D., Cao, H., Pellecchia, G., Alipanahi, B., Thiruvahindrapuram, B., Tong, X., Sun, Y., Cao, D., Zhang, T., et al. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.27 · Cited by 216
Self-citationEstrogens Suppress a Behavioral Phenotype in Zebrafish Mutants of the Autism Risk Gene, CNTNAP2
Hoffman, E. J., Turner, K. J., Fernandez, J. M., Cifuentes, D., Ghosh, M., Ijaz, S., Jain, R. A., Kubo, F., Bill, B., Baier, H., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.039 · Cited by 215
Self-citationLi, J., Cai, T., Jiang, Y. W., Chen, H., He, X., Chen, C., Li, X., Shao, Q., Xia, R., Li, Z., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.40 · Cited by 212
Shared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap
Gandal, M. J., Haney, J. R., Parikshak, N., Leppä, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17103 · Cited by 212
The polygenic architecture of schizophrenia — rethinking pathogenesis and nosology
Smeland, O. B., Frei, O., Dale, A. M., & Andreassen, O. A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0364-0 · Cited by 214
Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development
Lennox, A. L., Hoye, M. L., Jiang, R., Johnson-Kerner, B., Suit, L., Venkataramanan, S., Sheehan, C. J., Alsina, F. C., Fregeau, B., Aldinger, K. A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.042 · Cited by 210
Paternally inherited cis-regulatory structural variants are associated with autism
Brandler, W. M., Antaki, D., Gujral, M., Kleiber, M. L., Whitney, J., Maile, M. S., Hong, O., Chapman, T. R., Tan, S., Tandon, P., et al. (2018) · Science · doi:10.1126/science.aan2261 · Cited by 209
Self-citationiPSYCH-Broad Consortium, Satterstrom, F. K., Walters, R. K., Singh, T., Wigdor, E. M., Lescai, F., Demontis, D., Kosmicki, J. A., Grove, J., Stevens, C., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0527-8 · Cited by 209
The role of sex-differential biology in risk for autism spectrum disorder
Werling, D. M. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0112-8 · Cited by 208
Genetics and genomics of autism spectrum disorder: embracing complexity
De Rubeis, S., & Buxbaum, J. D. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv273 · Cited by 208
Collins, R. L., Brand, H., Redin, C. E., Hanscom, C., Antolik, C. W., Stone, M. R., Glessner, J., Mason, T., Pregno, G., Dorrani, N., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1158-6 · Cited by 208
Self-citationAntaki, D., Guevara, J., Maihofer, A. X., Klein, M., Gujral, M., Grove, J., Carey, C. E., Hong, O., Arranz, M. J., Hervas, A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01064-5 · Cited by 206
Histone H3 lysine K4 methylation and its role in learning and memory
Collins, B. E., Greer, C. B., Coleman, B. C., & Sweatt, J. D. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0251-8 · Cited by 209
Genetic contributions to autism spectrum disorder
Havdahl, A., Niarchou, M., Starnawska, A., Uddin, M., van der Merwe, C., & Warrier, V. (2021) · Psychological Medicine · doi:10.1017/s0033291721000192 · Cited by 211
Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder
Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J.-B., Fombonne, E., & O’Roak, B. J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.016 · Cited by 204
Self-citationDisruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID
van Bon, B. W. M., Coe, B. P., Bernier, R., Green, C., Gerdts, J., Witherspoon, K., Kleefstra, T., Willemsen, M. H., Kumar, R., Bosco, P., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.5 · Cited by 204
Self-citationDisrupted Intricacy of Histone H3K4 Methylation in Neurodevelopmental Disorders
Vallianatos, C. N., & Iwase, S. (2015) · Epigenomics · doi:10.2217/epi.15.1 · Cited by 204
Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders
Wang, T., Hoekzema, K., Vecchio, D., Wu, H., Sulovari, A., Coe, B. P., Gillentine, M. A., Wilfert, A. B., Jurado, L. A. P., Kvarnung, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18723-y · Cited by 204
A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder
Martin, J., Walters, R. K., Demontis, D., Mattheisen, M., Lee, S., Robinson, E., Brikell, I., Ghirardi, L., Larsson, H., Lichtenstein, P., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.11.026 · Cited by 203
Insights into genetics, human biology and disease gleaned from family based genomic studies
Posey, J. E., O’Donnell‐Luria, A., Chong, J. X., Harel, T., Jhangiani, S. N., Coban‐Akdemir, Z., Buyske, S. G., Pehli̇van, D., Carvalho, C. M. B., Baxter, S. M., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0408-7 · Cited by 202
Self-citationMVP predicts the pathogenicity of missense variants by deep learning
Qi, H., Zhang, H., Zhao, Y., Chen, C., Long, J. J., Chung, W. K., Guan, Y., & Shen, Y. (2021) · Nature Communications · doi:10.1038/s41467-020-20847-0 · Cited by 203
Quantifying the contribution of recessive coding variation to developmental disorders
Martin, H. C., Jones, W. D., McIntyre, R., Sanchez-Andrade, G., Sanderson, M., Stephenson, J. D., Jones, C. P., Handsaker, J., Gallone, G., Bruntraeger, M., et al. (2018) · Science · doi:10.1126/science.aar6731 · Cited by 201
Lombardo, M. V., Moon, H. M., Su, J., Palmer, T. D., Courchesne, E., & Pramparo, T. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.15 · Cited by 201
Zhang, Y., Lu, Q., Ye, Y., Huang, K., Liu, W., Wu, Y., Zhong, X., Li, B., Yu, Z., Travers, B. G., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02478-w · Cited by 207
Genotype to phenotype relationships in autism spectrum disorders
Chang, J., Gilman, S. R., Chiang, A. H., Sanders, S. J., & Vitkup, D. (2015) · Nature Neuroscience · doi:10.1038/nn.3907 · Cited by 197
Self-citationNambot, S., Thévenon, J., Kuentz, P., Duffourd, Y., Tisserant, É., Bruel, A., Mosca‐Boidron, A., Masurel, A., Lehalle, D., Jean‐Marçais, N., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.162 · Cited by 197
VarCards: an integrated genetic and clinical database for coding variants in the human genome
Li, J., Shi, L., Zhang, K., Zhang, Y., Hu, S., Zhao, T., Teng, H., Li, X., Jiang, Y. W., Ji, L., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1039 · Cited by 197
Timberlake, A. T., Choi, J., Zaidi, S., Lu, Q., Nelson-Williams, C. J., Brooks, E. D., Bilgüvar, K., Tikhonova, I., Mane, S., Yang, J. F., et al. (2016) · eLife · doi:10.7554/elife.20125 · Cited by 196
Self-citationThe BTBR mouse model of idiopathic autism – Current view on mechanisms
Meyza, K. Z., & Blanchard, D. C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.037 · Cited by 196
Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder
Wu, Y. E., Parikshak, N. N., Belgard, T. G., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4373 · Cited by 195
Patterns of de novo tandem repeat mutations and their role in autism
Mitra, I., Huang, B., Mousavi, N., Ma, N., Lamkin, M., Yanicky, R., Shleizer-Burko, S., Lohmueller, K. E., & Gymrek, M. (2021) · Nature · doi:10.1038/s41586-020-03078-7 · Cited by 194
Pizzo, L., Jensen, M., Polyak, A., Rosenfeld, J. A., Mannik, K., Krishnan, A., McCready, E., Pichon, O., Le Caignec, C., Van Dijck, A., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0266-3 · Cited by 193
Takata, A., Matsumoto, N., & Kato, T. (2017) · Nature Communications · doi:10.1038/ncomms14519 · Cited by 192
Aggarwala, V., & Voight, B. F. (2016) · Nature Genetics · doi:10.1038/ng.3511 · Cited by 189
De Novo Coding Variants Are Strongly Associated with Tourette Disorder
Willsey, A. J., Fernandez, T. V., Yu, D., King, R. A., Dietrich, A., Xing, J., Sanders, S. J., Mandell, J. D., Huang, A. Y., Richer, P., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.024 · Cited by 187
Self-citationHotspots of missense mutation identify neurodevelopmental disorder genes and functional domains
Geisheker, M. R., Heymann, G., Wang, T., Coe, B. P., Turner, T. N., Stessman, H. A. F., Hoekzema, K., Kvarnung, M., Shaw, M. A., Friend, K. L., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4589 · Cited by 187
Self-citationBehavioral phenotypes of genetic mouse models of autism
Kazdoba, T. M., Leach, P. T., & Crawley, J. N. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12256 · Cited by 187
De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability
Küry, S., van Woerden, G. M., Besnard, T., Proietti Onori, M., Latypova, X., Towne, M. C., Cho, M. T., Prescott, T. E., Ploeg, M. A., Sanders, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.10.003 · Cited by 185
Self-citationTranslational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5003 · Cited by 185
Mottron, L. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-0955-5 · Cited by 183
The landscape of tolerated genetic variation in humans and primates
(2023) · doi:10.1126/science.abn8197 · Cited by 182
Quesnel-Vallières, M., Dargaei, Z., Irimia, M., Gonatopoulos-Pournatzis, T., Ip, J. Y., Wu, M., Sterne-Weiler, T., Nakagawa, S., Woodin, M. A., Blencowe, B. J., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.033 · Cited by 178
Zech, M., Boesch, S., Maier, E. M., Borggraefe, I., Vill, K., Laccone, F. A., Pilshofer, V., Ceballos-Baumann, A., Alhaddad, B., Berutti, R., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.10.010 · Cited by 178
An Autism-Linked Mutation Disables Phosphorylation Control of UBE3A
Yi, J. J., Berrios, J., Newbern, J. M., Snider, W. D., Philpot, B. D., Hahn, K. M., & Zylka, M. J. (2015) · Cell · doi:10.1016/j.cell.2015.06.045 · Cited by 177
Zhang, Y., Li, N., Li, C., Zhang, Z., Teng, H., Wang, Y., Zhao, T., Shi, L., Zhang, K., Xia, K., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0699-8 · Cited by 177
Eising, E., Carrión-Castillo, A., Vino, A., Strand, E. A., Jakielski, K. J., Scerri, T. S., Hildebrand, M. S., Webster, R., Ma, A. S., Mazoyer, B. M., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0020-x · Cited by 177
Wnt signaling networks in autism spectrum disorder and intellectual disability
Kwan, V., Unda, B. K., & Singh, K. K. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9176-3 · Cited by 176
Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing
Parras, A., Anta, H., Santos‐Galindo, M., Swarup, V., Elorza, A., Nieto-González, J. L., Picó, S., Hernández, I. H., Díaz‐Hernandéz, J. I., Belloc, E., et al. (2018) · Nature · doi:10.1038/s41586-018-0423-5 · Cited by 175
Takata, A., Miyake, N., Tsurusaki, Y., Fukai, R., Miyatake, S., Koshimizu, E., Kushima, I., Okada, T., Morikawa, M., Uno, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.074 · Cited by 174
Regulating the human HECT E3 ligases
Sluimer, J., & Distel, B. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2848-2 · Cited by 174
Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
Yoon, S. H., Choi, J., Lee, W. Y., & Do, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040966 · Cited by 175
Self-citationDYRK1A and cognition: A lifelong relationship
Arbonés, M. L., Thomazeau, A., Nakano-Kobayashi, A., Hagiwara, M., & Delabar, J. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.010 · Cited by 174
Rethinking the fast-slow continuum of individual differences
Giudice, M. D. (2020) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2020.05.004 · Cited by 173
The development of autism spectrum disorders: variability and causal complexity
Wozniak, R. H., Leezenbaum, N. B., Northrup, J. B., West, K. L., & Iverson, J. M. (2016) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1426 · Cited by 172
Zebrafish Models of Neurodevelopmental Disorders: Past, Present, and Future
Sakai, C., Ijaz, S., & Hoffman, E. J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00294 · Cited by 172
Ankrd11 Is a Chromatin Regulator Involved in Autism that Is Essential for Neural Development
Gallagher, D., Voronova, A., Zander, M. A., Cancino, G. I., Bramall, A. N., Krause, M. P., Abad, C., Tekin, M., Neilsen, P. M., Callen, D. F., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.031 · Cited by 171
Wang, P., Lin, M., Pedrosa, E., Hrabovsky, A., Zhang, Z., Guo, W., Lachman, H. M., & Zheng, D. (2015) · Molecular Autism · doi:10.1186/s13229-015-0048-6 · Cited by 171
Richter, M., Murtaza, N., Scharrenberg, R., White, S. H., Johanns, O., Walker, S., Yuen, R. K. C., Schwanke, B., Bedürftig, B., Henis, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0025-5 · Cited by 169
Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP
Dijck, A. V., Silfhout, A. T. V., Cappuyns, E., van der Werf, I. M., Mancini, G. M. S., Tzschach, A., Bernier, R., Gozes, I., Eichler, E. E., Romano, C., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.1173 · Cited by 169
Self-citationHowrigan, D. P., Rose, S. A., Samocha, K. E., Fromer, M., Cerrato, F., Chen, W. J., Churchhouse, C., Chambert, K., Chandler, S. D., Daly, M. J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0564-3 · Cited by 168
The landscape of DNA methylation amid a perfect storm of autism aetiologies
Ciernia, A. V., & LaSalle, J. M. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.41 · Cited by 168
BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription
Dias, C., Estruch, S. B., Graham, S. A., McRae, J. F., Sawiak, S. J., Hurst, J. A., Joss, S. K., Holder, S., Morton, J. E. V., Turner, C., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.05.030 · Cited by 168
RAC1 Missense Mutations in Developmental Disorders with Diverse Phenotypes
Reijnders, M. R. F., Ansor, N. M., Kousi, M., Yue, W. W., Tan, P. L., Clarkson, K., Clayton-Smith, J., Corning, K., Jones, J. R., Lam, W. W. K., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.08.007 · Cited by 168
Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops
Mullins, C., Fishell, G., & Tsien, R. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.017 · Cited by 167
Autism spectrum disorder: insights into convergent mechanisms from transcriptomics
Quesnel-Vallières, M., Weatheritt, R. J., Cordes, S. P., & Blencowe, B. J. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0066-2 · Cited by 167
Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_4 · Cited by 167
Jasmine and Iris: population-scale structural variant comparison and analysis
Kirsche, M., Prabhu, G., Sherman, R. M., Ni, B., Battle, A. J., Aganezov, S. S., & Schatz, M. C. (2023) · Nature Methods · doi:10.1038/s41592-022-01753-3 · Cited by 167
Self-citationGussow, A. B., Copeland, B. R., Dhindsa, R. S., Wang, Q., Petrovski, S., Majoros, W. H., Allen, A. S., & Goldstein, D. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181604 · Cited by 165
Kctd13 deletion reduces synaptic transmission via increased RhoA
Escamilla, C. O., Filonova, I., Walker, A. K., Xuan, Z. X., Holehonnur, R., Espinosa, F., Liu, S., Thyme, S. B., López-García, I. A., Mendoza, D. B., et al. (2017) · Nature · doi:10.1038/nature24470 · Cited by 165
Current knowledge on the genetics of autism and propositions for future research
Bourgeron, T. (2016) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2016.05.004 · Cited by 164
Brain connectivity in autism spectrum disorder
Mohammad-Rezazadeh, I., Frohlich, J., Loo, S. K., & Jeste, S. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000301 · Cited by 163
Metadata
- Authors
- Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., Smith, J. D., Paeper, B., Nickerson, D. A., Dea, J., Dong, S., Gonzalez, L. E., Mandell, J. D., Mane, S. M., Murtha, M. T., Sullivan, C. A., Walker, M. F., Waqar, Z., Wei, L., Willsey, A. J., Yamrom, B., Lee, Y.-H., Grabowska, E., Dalkic, E., Wang, Z., Marks, S., Andrews, P., Leotta, A., Kendall, J., Hakker, I., Rosenbaum, J., Ma, B., Rodgers, L., Troge, J., Narzisi, G., Yoon, S., Schatz, M. C., Ye, K., McCombie, W. R., Shendure, J., Eichler, E. E., State, M. W., & Wigler, M.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Oregon Health & Science University (US)
- University of California, San Francisco (US)
- University of Washington (US)
- Peking University (CN)
- Yale University (US)
- Albert Einstein College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shendure, Jay
- Eichler, Evan E.
- State, Matthew W.
- Wigler, Michael
- ORCID
- Iossifov, Ivan
- O’Roak, Brian J.
- Sanders, Stephan J.
- Ronemus, Michael
- Krumm, Niklas
- Stessman, Holly A.
- Patterson, Karynne E.
- Smith, Joshua D.
- Nickerson, Deborah A.
- Dea, Jeanselle
- Dong, Shan
- Mandell, Jeffrey D.
- Mane, Shrikant M.
- Sullivan, Catherine A.
- Wei, Liping
- Willsey, A. Jeremy
- Yamrom, Boris
- Rodgers, Linda
- Narzisi, Giuseppe
- Schatz, Michael C.
- Ye, Kenny
- McCombie, W. Richard
- Shendure, Jay
- Eichler, Evan E.
- State, Matthew W.
- Wigler, Michael
- Venue
- Nature
- Published
- 2014-10-29
- Volume
- 515
- Issue
- 7526
- Pages
- 216-221
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4313871
- OpenAlex
- W2008627757
- Cited by
- 2,585
- References
- 51
- Citations by year
- 2026: 125 · 2025: 178 · 2024: 204 · 2023: 209 · 2022: 263 · 2021: 266 · 2020: 298 · 2019: 232 · 2018: 202 · 2017: 237 · 2016: 210 · 2015: 146 · 2014: 12
- FWCI
- 112.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Zonguldak Bülent Ecevit University Institutional Repository (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (1rc2hl103010-01, UL1TR000142)
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (RC2HL102925, RC2HL102926, RC2HL102923, UC2HL102924, RC2HL-103010, UC2HL102925, UC2HL102923, UC2HL103010, RC2HL102924, UC2HL102926)
- National Institute of Mental Health (R01MH101221)
- National Institute of General Medical Sciences (T32GM007266)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- autism spectrum disorder, de novo mutations, simplex families, missense mutations, copy number variation, sex differences, intellectual disability, schizophrenia, chromatin modifiers, exome sequencing, genetic architecture, affected siblings, synaptic genes, chromatin remodeling
- MeSH terms
- Child, Child Development Disorders, Pervasive, Female, Genes, Humans, Intelligence Tests, Male, Mutation, Reproducibility of Results, Cluster Analysis, Open Reading Frames, Genetic Predisposition to Disease, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
